Thu, 5 Nov
Shilpa Medicare
Record Q2 revenue of ₹538 Cr (+35%) and EBITDA of ₹151 Cr (28% margin), but gross margin fell roughly 700 bps and management deflected several key questions.
Summary ready
Earnings calls
Shilpa Medicare concalls
Every Shilpa Medicare earnings call we streamed: the live audio and our summary of what management said.
Calls
Q2 FY27: key takeaways
Call page →Record Q2 revenue of ₹538 Cr (+35%) and EBITDA of ₹151 Cr (28% margin), but gross margin fell roughly 700 bps and management deflected several key questions.
Outlook
No forward guidance given. Peptide utilisation comment deferred to next year's H2. No albumin revenue guidance.
Earlier call summaries
All →
17:41 IST
NSE
Earnings Call
Shilpa Medicare Earnings Call Transcript: Key Takeaways
Shilpa Medicare delivered a robust Q4 performance with revenue growing 30% YoY, driven by API and formulation scale-ups, but remains heavily dependent on lumpy licensing income and future global clinical trial successes.
13:49 IST
BSE
Earnings Call
Shilpa Medicare Earnings Call: Key Takeaways
Shilpa Medicare reported its highest-ever quarterly revenue of ₹439cr (+30% YoY) and full-year FY26 revenue of ₹1,549cr (+18% YoY), driven by API and formulation vertical integration.
18:33 IST
BSE
Earnings Call
Shilpa Medicare Earnings Call: Key Takeaways
Shilpa Medicare reported its highest-ever quarterly revenue and EBITDA, signaling a shift from a long investment cycle to asset sweating and operational leverage.
15:21 IST
BSE
Earnings Call
Shilpa Medicare Earnings Call: Key Takeaways
Shilpa Medicare delivered record FY26 performance with 18% revenue growth and 30% EBITDA growth. Strategy focuses on high-value CDMO partnerships, specialized formulations like NorUDCA, and a robust biosimilar pipeline.
13:08 IST
NSE
Earnings Call
Shilpa Medicare Earnings Call: Key Takeaways
Shilpa Medicare reported record quarterly revenue and EBITDA, signaling a shift from heavy R&D investment to commercial execution across API, formulations, and biologics.
Shilpa Medicare Ltd: key numbers
- Share price
- ₹923.00
- Market cap
- ₹18,052 Cr
- Revenue (annual)
- ₹1,539 Cr
- Net profit (annual)
- ₹243.3 Cr
- P/E (TTM)
- 54.3×Sector 37.9×
- Promoter holding
- 40.13%+0.00% QoQ
- FII holding
- 12.11%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.